Revisión | 23 DIC 13

Catéteres venosos centrales

Este artículo analiza los catéteres venosos centrales y las técnicas de inserción, así como la prevención y el tratamiento de las complicaciones.
Autor/a: Dres. Smith RN, Nolan JP BMJ 2013;347:f6570
INDICE:  1.  | 2. Referencias
Referencias

1 Waghorn DJ. Intravascular device-associated systemic infections: a 2 year analysis of cases in a district general hospital. J Hosp Infect 1994; 28:91-101.
2 McGee DC, Gould MK. Preventing complications of central venous catheterization. N
Engl J Med 2003;348:1123-33.
3 Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-8.
4 Monet X, Teboul J-L. Passive leg raising. Intensive Care Med 2008; 34:659-63.
5 Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 2012; 3:CD004084.
6 Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012; 40:2479-85.
7 Kellum JA. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2(1).
8 Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth 2013; 110:333-46.
9 Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65(suppl 1):S1-64.
10 Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792-801.
11 Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PloS One 2012;7:e44277.
12 National Institute for Health and Care Excellence. Guidance on the use of ultrasound locating devices for placing central venous catheters. TA49. 2002. http://guidance.nice. org.uk/TA49.
13 Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327:361.
14 Lamperti M, Bodenham AR, Pittiruti M, et al. International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med 2012; 38:1105-17.
15 Sharma A, Bodenham AR, Mallick A. Ultrasound-guided infraclavicular axillary vein cannulation for central venous access. Br J Anaesth 2004; 93:188-92.
16 Fragou M, Gravvanis A, Dimitriou V, Papalois A, Kouraklis G, Karabibis A, et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med 2011; 39:1607-12.
17 Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013; 11:71-80.
18 Albrecht K, Nave H, Breitmeier D, Panning B, Troger HD. Applied anatomy of the superior vena cava—the carina as a landmark to guide central venous catheter placement. Br J Anaesth 2004; 92:75-7.
19 Bion J, Richardson A, Hibbert P, Beer J, Abrusci T, McCutcheon M, et al. “Matching Michigan”: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Safe 2013; 22:110-23.
20 Hopkins S, Shaw K, Simpson L. English national point prevalence survey on healthcare associated infections and antimicrobial use, 2011: preliminary data. Health Protection Agency, 2012. www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1317134304594.
21 Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
22 Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
23 Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WSC, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev 2013; 6:CD007878.
24 Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. epic3 National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. 2013. www.uwl.ac.uk/sites/default/files/Academic-schools/College-of-Nursing-Midwifery-and-Healthcare/Web/Epic3/epic3_Consultation_Draft.pdf.
25 Dezfulian C, Lavelle J, Nallamothu BK, Kaufman SR, Saint S. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Crit Care Med 2003; 31:2385-90.
26 Van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2007;1:CD003295.
27 Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010; 75:1-11.
28 Webster J, Gillies D, O’Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2011; 11:CD003827.
29 Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25:1417-24.
30 O’Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012; 33:257-67.
31 Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-32.
32 Pronovost PJ, Goeschel CA, Colantuoni E, Watson S, Lubomski LH, Berenholtz SM, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010; 340:c309.
33 Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 2009; 27:4858-64.
34 Rooden CJ, Tesselaar ME, Osanto S, Rosendaal FR, Huisman MV. Deep vein thrombosis associated with central venous catheters—a review. J Thromb Haemostas 2005; 3:2409-19.
35 Akl EA, Vasireddi SR, Gunukula S, Yosuico VED, Barba M, Sperati F, et al. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev 2011;4:CD006468.
36 Kirkpatrick A, Rathbun S, Whitsett T, Raskob G. Prevention of central venous catheter-associated thrombosis: a meta-analysis. Am J Med 2007; 120:901e1-13.
37 Van Miert C, Hill R, Jones L. Interventions for restoring patency of occluded central venous catheter lumens. Cochrane Database Syst Rev 2012; 4:CD007119.
38 Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin 2008; 58:323-46.
39 Chopra V, Anand S, Hickner A, Buist M, Rogers MAM, Saint S, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013; 382:311-25.
40 Pikwer A, Akeson J, Lindgren S. Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 2012; 67:65-71.
41 Chopra V, Anand S, Krein SL, Chenoweth C, Saint S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 2012; 125:733-41.
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024